Maxacalcitol

马沙骨化醇

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMaxacalcitol
Drug Alias NamePreziosOxarolSch-209579OCTMC-1275
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D3 analoguesVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsHyperparathyroidism, SecondaryHyperparathyroidism
Global Approved IndicationsHyperparathyroidism, SecondaryHyperparathyroidism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2000/07/03
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperparathyroidism, SecondaryHyperparathyroidism
Inactive IndicationsN/A

Other Information

ATC CodeA11CC
Related LinksKEGG